New treatment against Duchenne muscular dystrophy

EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Duvyzat (givinostat) as a treatment for Duchenne muscular dystrophy (DMD) in…

Leave a Reply

Your email address will not be published. Required fields are marked *